No Data
No Data
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3
Maxim Group Upgrades Nexalin Technology(NXL.US) to Buy Rating, Announces Target Price $5
Maxim Group Upgrades Nexalin Technology to Buy, Announces $5 Price Target
Nexalin Technology Analyst Ratings
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
10-K: FY2024 Annual Report